Polymer‐lipid hybrid nanoparticles: A novel drug delivery system for enhancing the activity of Psoralen against breast cancer
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Pharmaceutics"
DOI: 10.1016/j.ijpharm.2019.03.006
Abstract: Graphical abstract Figure. No caption available. ABSTRACT A polymer‐lipid hybrid nanocarrier was developed to encapsulate psoralen (PSO) to improve its water solubility and bioavailability. The effects of PSO‐loaded polymer‐lipid hybrid nanoparticles (PSO‐PLNs) on breast cancer… read more here.
Keywords: breast; pso plns; lipid hybrid; polymer lipid ... See more keywords